Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration- Letter to Health Care Providers

February 27, 2023 The U.S. Food and Drug Administration (FDA) is informing health care providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and the Trifecta Valve with Glide Technology (Trifecta GT), which feature leaflets externally mounted to the valve frame. Information from published literature…

Global Pharma Healthcare Issues Voluntary Nationwide Recall of Delsam Pharma Artificial Eye Ointment Due to Possible Microbial Contamination

Summary Company Announcement Date: February 23, 2023 FDA Publish Date: February 24, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to possible microbial contamination Company Name: Global Pharma Healthcare Brand Name: Brand Name(s) Delsam Pharma’s Product Description: Product Description Artificial Eye Ointment Company Announcement FOR IMMEDIATE RELEASE – February 23, 2023, Global…

Evaluation of Airborne Chemicals from Neonatal Incubators – Letter to Health Care Providers

February 23, 2023 The U.S. Food and Drug Administration (FDA) is informing health care providers and facilities about the potential for exposure to airborne chemicals that may be released from neonatal incubators. The FDA is evaluating published literature that reports elevated levels of formaldehyde, cyclohexanone, and other volatile chemicals (such as human-made chemicals used and…

nanoMaterials Discovery Corporation Issues Voluntary Nationwide Recall of its Alcohol Antiseptic 80% Alcohol Solution

Summary Company Announcement Date: February 14, 2023 FDA Publish Date: February 21, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to presence of methanol Company Name: nanoMaterials Discovery Corporation Brand Name: Brand Name(s) nanoMaterials Discovery Corporation Product Description: Product Description Hand Sanitizer Company Announcement FOR IMMEDIATE RELEASE – February 14, 2023 –…

Philips Respironics Recalls Certain Reworked Philips Respironics Trilogy 100/200 and Garbin Ventilators Due to Potential for Silicone Foam Adhesion Failure and Residual PE‐PUR Foam Debris

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Name: Philips Respironics Trilogy 100, Trilogy 200, and Garbin Plus ventilators Product Models and Serial Numbers: See recall database entries Distribution Dates: March 1, 2022, to…

Actualizado: Problemas de mamografía en Advanced Women Imaging en Guttenberg, NJ

English Actualización – 7 de febrero de 2023: El certificado de la Ley de estándares de calidad de mamografía (MQSA, por sus siglas en inglés) para Advanced Women Imaging (en inglés), en 6414 Bergenline Avenue, West New York, NJ (Bergenline) fue revocado hasta el 4 de enero de 2025. Actualmente, el centro no está acreditado…

Volt Candy Issues Voluntary Nationwide Recall of PrimeZen Black 6000 Capsules Due to Presence of Sildenafil and Tadalafil

Summary Company Announcement Date: February 13, 2023 FDA Publish Date: February 13, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Product contains undeclared tadalafil and sildenafil Company Name: Volt Candy Brand Name: Brand Name(s) Product Description: Product Description PrimeZEN Black 6000 male enhancement capsules Company Announcement FOR IMMEDIATE RELEASE – 2/13/2023 – Pomona,…

Universal Meditech Inc. Issues Nationwide Recall of Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test Kit

Summary Company Announcement Date: February 09, 2023 FDA Publish Date: February 10, 2023 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Products were distributed without appropriate premarket clearance or approval which potentially could result in inaccurate test results due to lack of performance evaluation by the FDA. Company Name: Universal Meditech Inc. Brand…